Stoke Therapeutics, Inc. (STOK) › Shares OutstandingStoke Therapeutics, Inc. (STOK) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2018: 727.4K2019: 32.86M2020: 36.58M2021: 36.90M2022: 39.44M2023: 45.92M2024: 54.03M2025: 58.92M58.92M2018Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202558.92M+9.0%202454.03M+17.7%202345.92M+16.4%202239.44M+6.9%202136.90M+0.9%202036.58M+11.3%201932.86M+4417.6%2018727.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share